Truist Securities Initiates Coverage On Axogen with Buy Rating, Announces Price Target of $60
Truist Securities analyst Ravi Misra initiates coverage on Axogen (NASDAQ:AXGN) with a Buy rating and announces Price Target of $60.
Stocks · News reference
8-K filing — Axogen, Inc. (AXGN)
Filed: 2026-07-29 AccNo: 0000805928-26-000091 Size: 7 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading